MENU
ABUS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Arbutus Biopharma (ABUS) Ownership - Who owns Arbutus Biopharma?

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
701 Veterans Circle
Phone
+1 267 469-0914
Employees
73
Web
http://www.arbutusbio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
676.09M
P/E Ratio
N/A
Total Cash
112.71M
Projected Growth
N/A
Total Debt
1.19M
Revenue
6.4M
Risk (Beta)
0.60
Dividend Yield
N/A
Total Cash/Share
0.59
Total Debt/Equity
N/A
Revenue/Share
0.03 USD as % of share price

Fundamentals

ABUS
Capitalization
676M
P/E Ratio
N/A
Risk (Beta)
0.60
Dividend Yield
N/A
Total Cash
113M
Total Cash/Share
0.59
Total Debt
1.19M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.03%
Revenue
6.4M
ROE
N/A
Book Value
79.2M
P/B Ratio
8.67
Cash Flow
N/A
Earnings
-0.41
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.42B
Current Ratio
6.01
Current Revenue Per Employee
40090.91
Dividends Per Share - Security
N/A
EBITDA
-75.1M
Float
N/A
Float - Current
N/A
Gross Income Margin
-1.77
Revenue To Assets
-57.29
Shares Held By Institutions
543M
Shares Outstanding - Current
192M
Total Liabilities
37.9M
Total Volume MTD
N/A
Value
-1
Gain YTD
9.480
View a ticker or compare two or three
ABUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of drugs to improve the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
701 Veterans Circle
Phone
+1 267 469-0914
Employees
73
Web
http://www.arbutusbio.com